These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7742525)

  • 41. Severe folate restriction results in depletion of and alteration in the composition of the intracellular folate pool, moderate sensitization to methotrexate and trimetrexate, upregulation of endogenous DHFR activity, and overexpression of metallothionein II and folate receptor alpha that, upon folate repletion, confer drug resistance to CHL cells.
    Zhu WY; Bunni M; Priest DG; DiCapua JL; Dressler JM; Chen Z; Melera PW
    J Exp Ther Oncol; 2002; 2(5):264-77. PubMed ID: 12416030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biochemical pharmacology of the lipophilic antifolate, trimetrexate.
    Jackson RC; Fry DW; Boritzki TJ; Besserer JA; Leopold WR; Sloan BJ; Elslager EF
    Adv Enzyme Regul; 1984; 22():187-206. PubMed ID: 6236675
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A double-blind placebo-controlled randomized phase III trial of 5-fluorouracil and leucovorin, plus or minus trimetrexate, in previously untreated patients with advanced colorectal cancer.
    Blanke CD; Shultz J; Cox J; Modiano M; Isaacs R; Kasimis B; Schilsky R; Fleagle J; Moore M; Kemeny N; Carlin D; Hammershaimb L; Haller D
    Ann Oncol; 2002 Jan; 13(1):87-91. PubMed ID: 11863117
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in intracellular folate metabolism during high-dose methotrexate and Leucovorin rescue therapy in children with acute lymphoblastic leukemia.
    Oosterom N; de Jonge R; Smith DEC; Pieters R; Tissing WJE; Fiocco M; van Zelst BD; van den Heuvel-Eibrink MM; Heil SG
    PLoS One; 2019; 14(9):e0221591. PubMed ID: 31527879
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of the effect of AG337, a novel lipophilic thymidylate synthase inhibitor, on human head and neck and human leukemia cell lines.
    McGuire JJ; Canestrari JG; Nagel GS
    Int J Oncol; 1999 Dec; 15(6):1245-50. PubMed ID: 10568835
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of leucovorin protection from variety of antifolates in human lymphoid cell lines.
    Browman GP; Spiegl P; Booker L; Rosowsky A
    Cancer Chemother Pharmacol; 1985; 15(2):111-4. PubMed ID: 3874720
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expression.
    Gorlick R; Goker E; Trippett T; Steinherz P; Elisseyeff Y; Mazumdar M; Flintoff WF; Bertino JR
    Blood; 1997 Feb; 89(3):1013-8. PubMed ID: 9028333
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
    Joannon P; Oviedo I; Campbell M; Tordecilla J
    Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A gene transfer strategy for making bone marrow cells resistant to trimetrexate.
    Spencer HT; Sleep SE; Rehg JE; Blakley RL; Sorrentino BP
    Blood; 1996 Mar; 87(6):2579-87. PubMed ID: 8630426
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rapid development of resistance to antifolates in vitro: possible clinical implication.
    Sobrero A; Aschele C; Rosso R; Nicolin A; Bertino JR
    J Natl Cancer Inst; 1991 Jan; 83(1):24-8. PubMed ID: 1824599
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.
    Mahoney DH; Shuster JJ; Nitschke R; Lauer SJ; Steuber CP; Winick N; Camitta B
    J Clin Oncol; 1998 May; 16(5):1712-22. PubMed ID: 9586883
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biochemical and growth inhibition studies of methotrexate and aminopterin analogues containing a tetrazole ring in place of the gamma-carboxyl group.
    McGuire JJ; Russell CA; Bolanowska WE; Freitag CM; Jones CS; Kalman TI
    Cancer Res; 1990 Mar; 50(6):1726-31. PubMed ID: 2306727
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Double modulation of 5-fluorouracil by trimetrexate and leucovorin in patients with advanced colorectal carcinoma.
    Machiavelli MR; Salum G; Pérez JE; Ortiz EH; Romero AO; Bologna F; Vallejo CT; Lacava JA; Dominguez ME; Leone BA
    Am J Clin Oncol; 2004 Apr; 27(2):149-54. PubMed ID: 15057154
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Determinants of the disparate antitumor activities of (6R)-5,10-dideaza-5,6,7,8-tetrahydrofolate and methotrexate toward human lymphoblastic leukemia cells, characterized by severely impaired antifolate membrane transport.
    Matherly LH; Angeles SM; McGuire JJ
    Biochem Pharmacol; 1993 Dec; 46(12):2185-95. PubMed ID: 7506026
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-dose methotrexate and/or leucovorin rescue for the treatment of children with lymphoblastic malignancies: do we really know why, when and how?
    Sterba J; Valík D; Bajciová V; Kadlecová V; Gregorová V; Mendelová D
    Neoplasma; 2005; 52(6):456-63. PubMed ID: 16284689
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential effects of the antifolates methotrexate, aminopterin and trimetrexate on murine haemopoietic progenitor cells.
    Stromhaug A; Slordal L; Warren DJ
    Br J Haematol; 1996 Mar; 92(3):514-20. PubMed ID: 8616011
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of methotrexate and of the "nonclassical" folate antagonist trimetrexate on human leukemia cells.
    Rodenhuis S; McGuire JJ; Sawicki WL; Bertino JR
    Leukemia; 1987 Feb; 1(2):116-20. PubMed ID: 2959824
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elevated dihydrofolate reductase and impaired methotrexate transport as elements in methotrexate resistance in childhood acute lymphoblastic leukemia.
    Matherly LH; Taub JW; Ravindranath Y; Proefke SA; Wong SC; Gimotty P; Buck S; Wright JE; Rosowsky A
    Blood; 1995 Jan; 85(2):500-9. PubMed ID: 7812005
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiple mechanisms of resistance to methotrexate and novel antifolates in human CCRF-CEM leukemia cells and their implications for folate homeostasis.
    Mauritz R; Peters GJ; Priest DG; Assaraf YG; Drori S; Kathmann I; Noordhuis P; Bunni MA; Rosowsky A; Schornagel JH; Pinedo HM; Jansen G
    Biochem Pharmacol; 2002 Jan; 63(2):105-15. PubMed ID: 11841783
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glutamic Acid Increased Methotrexate Polyglutamation and Cytotoxicity in a CCRF-SB Acute Lymphoblastic Leukemia Cell Line.
    Mendoza-Santiago A; Becerra E; Garay E; Bah M; Berumen-Segura L; Escobar-Cabrera J; Hernández-Pérez A; García-Alcocer G
    Medicina (Kaunas); 2019 Nov; 55(12):. PubMed ID: 31779260
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.